137 related articles for article (PubMed ID: 3469997)
1. Short-term in vitro chemosensitivity testing of tumours of the ovary, cervix and uterus. Measurement of DNA metabolism by 3H thymidine incorporation.
Khoo SK; Hurst T; Webb MJ; Mackay EV
Aust N Z J Obstet Gynaecol; 1986 Nov; 26(4):288-94. PubMed ID: 3469997
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitivity testing of ovarian cancer: results of a rapid in vitro biochemical assay.
Khoo SK; Hurst T; Webb MJ
Aust N Z J Obstet Gynaecol; 1985 Aug; 25(3):215-20. PubMed ID: 3866561
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin chemotherapy of ovarian cancer: is short-term in vitro chemosensitivity predictive of long-term patient survival?
Khoo SK; Hurst T; Webb MJ; Dickie G; Kearsley J; Parsons PG; Mackay EV
Aust N Z J Obstet Gynaecol; 1988 Nov; 28(4):313-7. PubMed ID: 3250450
[TBL] [Abstract][Full Text] [Related]
4. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
Eidtmann H; Jonat W; Maass H
Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin.
Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
Anticancer Res; 2005; 25(6C):4499-502. PubMed ID: 16334133
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of in vitro drug sensitivity testing based on short-term effects on DNA and RNA metabolism in ovarian cancer.
Khoo SK; Hurst T; Webb MJ; Dickie G; Kearsley J; Parsons PG; Mackay EV
J Surg Oncol; 1989 Jul; 41(3):201-5. PubMed ID: 2747246
[TBL] [Abstract][Full Text] [Related]
7. Comparison of an antimetabolic assay and an antiproliferative assay, both using 3H-thymidine incorporation, to test drug sensitivity of human tumors.
Zaffaroni N; Silvestrini R; Grignolio E; Villa R; DeMarco C
Int J Cell Cloning; 1988 Nov; 6(6):392-403. PubMed ID: 2466088
[TBL] [Abstract][Full Text] [Related]
8. Applications of a human tumour clonogenic cell culture system in gynaecological oncology: review and personal experience.
Verheijen RH; Herman CJ; Kenemans P
Eur J Obstet Gynecol Reprod Biol; 1984 Apr; 17(1):43-51. PubMed ID: 6734882
[TBL] [Abstract][Full Text] [Related]
9. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
Takamizawa H; Sekiya S; Iwasawa H; Ishige H; Tokita H; Tanaka N
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
[TBL] [Abstract][Full Text] [Related]
10. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
[TBL] [Abstract][Full Text] [Related]
11. [Scintillation counting as an in vitro method for assessing the pretherapeutic effectiveness of planned tumor chemotherapy in patients with ovarian cancer].
Behling H; Krafft W; Wagner F
Zentralbl Gynakol; 1987; 109(1):42-8. PubMed ID: 3577462
[TBL] [Abstract][Full Text] [Related]
12. The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours.
O'Toole SA; Sheppard BL; McGuinness EP; Gleeson NC; Yoneda M; Bonnar J
Cancer Detect Prev; 2003; 27(1):47-54. PubMed ID: 12600417
[TBL] [Abstract][Full Text] [Related]
13. [In vitro chemosensitivity test by human tumor colony forming assay].
Kanamaru H; Hashimura T; Kakehi Y; Kyu LN; Yoshida O
Hinyokika Kiyo; 1988 Nov; 34(11):1917-21. PubMed ID: 3242365
[TBL] [Abstract][Full Text] [Related]
14. Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Fuller AF; Krane IM; Budzik GP; Donahoe PK
Gynecol Oncol; 1985 Oct; 22(2):135-48. PubMed ID: 3932140
[TBL] [Abstract][Full Text] [Related]
15. [Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
Krafft W; Preibsche W; Marzotko F
Arch Geschwulstforsch; 1973; 41(3):241-7. PubMed ID: 4732846
[No Abstract] [Full Text] [Related]
16. In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy?
Welander CE; Homesley HD; Jobson VW
Am J Obstet Gynecol; 1983 Sep; 147(2):188-95. PubMed ID: 6614100
[TBL] [Abstract][Full Text] [Related]
17. Soft agarose culture human tumour colony forming assay for drug sensitivity testing: [3H]-thymidine incorporation vs colony counting.
Jones CA; Tsukamoto T; O'Brien PC; Uhl CB; Alley MC; Lieber MM
Br J Cancer; 1985 Sep; 52(3):303-10. PubMed ID: 4041359
[TBL] [Abstract][Full Text] [Related]
18. [Value of the tumor colony assay in therapy planning in malignant ovarian tumors].
Schieder K; Kölbl H; Bieglmayer C
Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):41-4. PubMed ID: 3569826
[TBL] [Abstract][Full Text] [Related]
19. A discussion of the results of chemotherapy on gynecological cancer and the host's immune response.
Trelford JD
Proc Natl Cancer Conf; 1970; 6():365-85. PubMed ID: 5458106
[No Abstract] [Full Text] [Related]
20. Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium.
Pecorelli S; Angioli R; Favalli G; Odicino F
Cancer Chemother Biol Response Modif; 2003; 21():565-84. PubMed ID: 15338764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
